Filter
6275
Filtered Results: 6275
Text search:
social
impact
assessment
Featured
Recommendations
537
New Publications
1667
Language
Document type
No document type
3579
Studies & Reports
1120
Guidelines
705
Manuals
330
Strategic & Response Plan
277
Training Material
99
Fact sheets
71
Situation Updates
60
Resource Platforms
20
Infographics
6
Brochures
5
Online Courses
3
Countries / Regions
Global
279
India
195
Kenya
179
Myanmar / Burma
141
Ethiopia
130
South Africa
129
Western and Central Europe
125
Nepal
124
Sierra Leone
116
Liberia
116
Nigeria
114
Uganda
114
Syria
100
Tanzania
95
Bangladesh
89
Zambia
83
Malawi
81
Ukraine
81
Rwanda
80
Latin America and the Carribbean
80
Africa
76
Ghana
72
Namibia
66
Congo, Democratic Republic of
62
Philippines
51
South Sudan
50
South–East Asia Region
47
Cambodia
41
Lesotho
41
Eastern Europe
41
Guinea
40
Yemen
37
Indonesia
36
Mozambique
36
Haiti
34
Asia
34
Zimbabwe
33
Brazil
30
East and Southern Africa
29
West and Central Africa
29
Russia
28
Pakistan
27
Afghanistan
27
Middle East and North Africa
26
Senegal
25
Botswana
24
Eastern Europe and Central Asia
24
Lebanon
23
Burkina Faso
22
Jordan
22
Venezuela
21
Sudan
18
Cameroon
17
Somalia
17
Colombia
17
Germany
16
Vietnam
15
Thailand
14
Central African Republic
14
Tajikistan
14
Western Pacific Region
13
USA
12
Eswatini/ Swaziland
12
Moldova
12
Benin
11
Iraq
10
Turkey
9
Albania
9
Laos
9
China
8
Peru
8
Madagascar
8
Georgia
8
Mali
7
Sri Lanka
7
Palestine
7
Burundi
6
Chile
6
Paraguay
6
Iran
6
Jamaica
6
Guinea-Bissau
5
Côte d’Ivoire / Ivory Coast
5
Saudi Arabia
5
Chad
5
Argentina
5
Ecuador
5
Poland
5
Southern Africa
5
Romania
5
Kazakhstan
5
United Kingdom
5
Togo
4
Egypt
4
Papua New Guinea
4
North Macedonia
4
Bolivia
4
Greece
4
Libya
4
Angola
4
Timor Leste/ East Timor
4
Kyrgyzstan
4
North America
4
Turkmenistan
4
Spain
4
Gambia
3
Hungary
3
Croatia
3
El Salvador
3
Mexico
3
Bhutan
3
Italy
3
Canada
3
Mauritius
3
Portugal
3
Bosnia and Herzegovina
3
Niger
2
Malaysia
2
Singapore
2
Guatemala
2
Other region
2
Fiji
2
Djibouti
2
Armenia
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Japan
2
France
2
Belarus
2
Morocco
1
Ireland
1
Vanuatu
1
Dominican Republic
1
Serbia
1
Honduras
1
Nicaragua
1
North Korea
1
Mongolia
1
Qatar
1
Lithuania
1
Belgium
1
Maldives
1
Tunisia
1
Azerbaijan
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
2288
Public Health
358
Key Resources
341
Clinical Guidelines
336
Women & Child Health
330
Capacity Building
126
Pharmacy & Technologies
24
Annual Report MEDBOX
1
General Guidelines
1
Protection & Security
1
Toolboxes
Mental Health
621
COVID-19
548
HIV
428
Planetary Health
343
Disability
288
TB
242
Conflict
223
Caregiver
174
Rapid Response
170
Ebola
147
Global Health Education
134
Refugee
125
AMR
121
Natural Hazards
117
NCDs
117
NTDs
105
Pharmacy
71
Health Financing Toolbox
52
Polio
41
Specific Hazards
34
Cholera
30
Zika
28
Social Ethics
24
Typhoon
6
South Sudan
2
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
The world is off track to make significant progress towards universal health coverage (UHC) (SDG target 3.8) by 2030 as improvements to health services coverage have stagnated since 2015, and the proportion of the population that faced catastrophic levels of out-of-pocket (OOP) health spending has i...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and risk communication. All efforts must b...
Sound periodic programme reviews provide opportunities for countries to objectively assess progress and take corrective action to sustain or get back on track towards achieving their medium and long-term programme goals. It reflects people’s diverse needs, enables efficient use of health system re...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many years. Now, as focus shifts from global to national progress, we call on members and colleagues to advocate for greater action on CVD in your local setti...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
Background
Cardiovascular diseases (CVDs) are one of the global leading causes of concern due to the rising prevalence and consequence of mortality and disability with a heavy economic burden. The objective of the current study was to analyze the trend in CVD incidence, mortality, and mortality-to-...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
